Videos

Bachem Capabilities to Address the New FDA Guideline for Synthetic Peptides

Scientific and regulatory challenges remain a big hurdle on the way to successful approval of generic drugs falling under this guideline.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters